Rates and trends in stage‐specific prostate cancer incidence by age and race/ethnicity, 2000–2017

作者：Yubo Cao, Wei Zhang, Yue Li, Jia Fu, Hongyuan Li, Xiulin Li, Xue Gao, Kaiyu Zhang, Sa Liu · 发表于：The Prostate · 年份：2021 · DOI：10.1002/pros.24204 · 被引用次数：22 · 研究领域：Prostate Cancer Diagnosis and Treatment、Global Cancer Incidence and Screening、Prostate Cancer Treatment and Research

BACKGROUND: The 2008 and 2012 United States Preventive Services Task Force (USPSTF) recommendations against prostate-specific antigen (PSA) screening have led to changes in the incidence pattern of prostate cancer. We sought to examine rates and trends in stage-specific prostate cancer incidence by age and race/ethnicity using the most recent data obtained from Surveillance, Epidemiology, and End Results (SEER) program. METHODS: SEER*Stat version 8.3.6 was used to analyze annual prostate cancer incidence rates between 2000 and 2017 according to the SEER summary stage, age group, and race/ethnicity group. Incidence rates per 100,000 men were calculated and age-adjusted to 2000 US standard population. Annual percentage change (APC) was performed to identify the trend in prostate cancer incidence. RESULTS: Between 2008 and 2012, trends in incidence of overall and localized prostate cancer significantly declined in comparison with between 2000 and 2007 (APC, -5.4 and -6.0, respectively). However, there was an increase in the incidence rate of both overall and localized prostate cancer from 2014 to 2017 (43.3-46 and 34-34.9 per 100,000 men, respectively). The incidence of regional prostate cancer significantly increased between 2013 and 2017 (5.9-6.8 per 100,000 men; APC, 4.3). Distant disease incidence increased continually between 2008 and 2012 (2.9-3.3 per 100,000 men; APC, 2.3) and between 2013 and 2017 (3.4-4.3 per 100,000 men; APC, 6.0). In addition, these increases in incid...